Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ARG1 | P05089 | 2/20 | 0.31 |
| ▸ | ARG2 | P78540 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13202057 | 0.90 | CA12 (0.37) | GAAKDM4EL3MBTL1KMT2AARG1 | |
| SCHEMBL5400361 | 0.82 | GAA (0.40) | GAAKDM4EL3MBTL1KMT2A | |
| SCHEMBL2962376 | 0.82 | GAA (0.40) | GAAKDM4EL3MBTL1KMT2A | |
| SCHEMBL2963209 | 0.82 | GAA (0.40) | GAAKDM4EL3MBTL1KMT2A | |
| SCHEMBL18329616 | 0.82 | GAA (0.40) | GAAKDM4EL3MBTL1KMT2A | |
| Hydrochloric Acid SCHEMBL5048328 | 0.81 | GAA (0.42) | GAAKDM4EL3MBTL1KMT2A | |
| SCHEMBL870336 | 0.79 | GAA (0.38) | GAAKDM4EL3MBTL1KMT2A | |
| SCHEMBL15180169 | 0.78 | — | — | |
| SCHEMBL17517789 | 0.78 | GAA (0.40) | GAAKDM4EL3MBTL1KMT2A | |
| SCHEMBL7044879 | 0.78 | GBA1 (0.43) | GAAKDM4EKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112920165-A | Spin-labeled naphthalimide oxygen-containing compound and application thereof | 沈阳药科大学 | 2021-06-08 | — | — | CN | disclosed |
| CN-111253368-B | Stable nitroxide radical modified naphthalimide compound and application thereof | 沈阳药科大学 | 2020-12-25 | — | — | CN | disclosed |
| CN-111253368-A | Stable nitroxide radical modified naphthalimide compound and application thereof | 沈阳药科大学 | 2020-06-09 | — | — | CN | disclosed |
| EP-3310819-B1 | COMPOSITION FOR IMMEDIATELY ENDING RADICAL POLYMERIZATION | BASF SE (DE) | 2019-06-12 | — | — | EP | disclosed |
| US-10221255-B2 | Composition for the immediate stopping of a free-radical polymerization | BASF SE (DE) | 2019-03-05 | — | — | US | disclosed |
| US-20180171035-A1 | COMPOSITION FOR THE IMMEDIATE STOPPING OF A FREE-RADICAL POLYMERIZATION | BASF SE (DE) | 2018-06-21 | — | — | US | disclosed |
| US-20180171035-A1 | COMPOSITION FOR THE IMMEDIATE STOPPING OF A FREE-RADICAL POLYMERIZATION | BASF SE (DE) | 2018-06-21 | — | — | US | disclosed |
| WO-2016202883-A1 | COMPOSITION FOR IMMEDIATELY ENDING RADICAL POLYMERIZATION | BASF SE (DE) | 2016-12-22 | — | — | WO | disclosed |
| EP-1297038-B1 | RUBBER-CONTAINING STYRENE POLYMERS WITH IMPROVED IMPACT RESISTANCE | BASF AG (DE) | 2006-08-02 | — | — | EP | disclosed |
| EP-1144353-B1 | METHOD FOR STABILIZING CHEMICAL COMPOUNDS CONTAINING AT LEAST ONE ETHYLENICALLY UNSATURATED BOND IN ORDER TO PREVENT UNDESIRABLE RADICAL POLYMERIZATION | BASF AG (DE) | 2005-12-28 | — | — | EP | disclosed |
| EP-1144353-A3 | METHOD FOR STABILIZING CHEMICAL COMPOUNDS CONTAINING AT LEAST ONE ETHYLENICALLY UNSATURATED BOND IN ORDER TO PREVENT UNDESIRABLE RADICAL POLYMERIZATION | BASF AKTIENGESELLSCHAFT (DE) | 2002-12-18 | — | — | EP | disclosed |
| EP-1175452-A1 | METHOD FOR PRODUCING BLOCK COPOLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 2002-01-30 | — | — | EP | disclosed |
| EP-1144353-A2 | METHOD FOR STABILIZING CHEMICAL COMPOUNDS CONTAINING AT LEAST ONE ETHYLENICALLY UNSATURATED BOND IN ORDER TO PREVENT UNDESIRABLE RADICAL POLYMERIZATION | BASF AKTIENGESELLSCHAFT (DE) | 2001-10-17 | — | — | EP | disclosed |
| US-H1957-H1 | ADDING A PHENOTHIAZINE-CONTAINING SOLUTION WHOSE SOLVENT COMPRISES AT LEAST 50% OF ITS WEIGHT OF AN N-ALKYLPYRROLIDONE | BASF AKTIENGESELLSCHAFT (DE) | 2001-04-03 | — | — | US | disclosed |
| EP-1056711-A1 | PROCESS FOR STABILISING (METHA)ACRYLIC ESTERS AGAINST UNWANTED RADICAL POLYMERISATION | BASF AKTIENGESELLSCHAFT (DE) | 2000-12-06 | — | — | EP | disclosed |
| WO-2000063267-A1 | METHOD FOR PRODUCING BLOCK COPOLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 2000-10-26 | — | — | WO | disclosed |
| WO-2000034220-A2 | METHOD FOR STABILIZING CHEMICAL COMPOUNDS CONTAINING AT LEAST ONE ETHYLENICALLY UNSATURATED BOND IN ORDER TO PREVENT UNDESIRABLE RADICAL POLYMERIZATION | BASF AKTIENGESELLSCHAFT (DE) | 2000-06-15 | — | — | WO | disclosed |
| EP-0991671-A1 | METHOD FOR AQUEOUS EMULSION POLYMERIZATION INITIATED BY FREE-RADICALS, FOR PRODUCING AN AQUEOUS POLYMER DISPERSION | BASF AKTIENGESELLSCHAFT (DE) | 2000-04-12 | — | — | EP | disclosed |
| WO-1999007664-A1 | PROCESS FOR STABILISING (METHA)ACRYLIC ACID ESTERS AGAINST UNWANTED RADICAL POLYMERISATION | BASF AKTIENGESELLSCHAFT (DE) | 1999-02-18 | — | — | WO | disclosed |
| WO-1999000426-A1 | METHOD FOR AQUEOUS EMULSION POLYMERIZATION INITIATED BY FREE-RADICALS, FOR PRODUCING AN AQUEOUS POLYMER DISPERSION | BASF AKTIENGESELLSCHAFT (DE) | 1999-01-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10221255-B2 | Composition for the immediate stopping of a free-radical polymerization | FASTKD5, TYK2, FASTKD1 | GAA 4489/4885KDM4E 2885/4885L3MBTL1 3957/4885 |
| US-20180171035-A1 | COMPOSITION FOR THE IMMEDIATE STOPPING OF A FREE-RADICAL POLYMERIZATION | FASTKD5, TYK2, FASTKD1 | GAA 4489/4885KDM4E 2885/4885L3MBTL1 3957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.